KAT6B and prostate carcinoma: What’s more, KAT5 and KAT6B positively regulated prostate cancer cell proliferation through phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway, which was aberrantly activated in hepatocellular carcinoma [12].